Literature DB >> 23726841

miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII.

Ting-Hui Chu1, Cheng-Chieh Yang, Chung-Ji Liu, Mann-Tin Lui, Shu-Chun Lin, Kuo-Wei Chang.   

Abstract

miR-211 up-regulation and transforming growth factor-β type II receptor (TGFβRII) down-regulation are associated with poor prognosis of head and neck squamous cell carcinoma (HNSCC). miR-211 directly targets TGFβRII with the miR-211-TGFβRII-c-Myc axis promoting HNSCC progression. An inverse correlation of miR-211 and TGFβRII expression was found in metastatic HNSCC samples. After 4-nitroquinoline 1-oxide induction, more severe epithelial tumorigenesis was detected on K14-miR-211 transgenic mouse dorsal tongues. Human metastatic lesions and mouse tongue tumors showed increased nuclear c-Myc expression. A novel role for miR-211 in the regulation of TGFβRII and c-Myc during tumorigenesis being revealed should help to develop anti-HNSCC therapies.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Carcinoma; Head and neck; TGFβRII; Transgenic mouse; c-Myc; miR-211

Mesh:

Substances:

Year:  2013        PMID: 23726841     DOI: 10.1016/j.canlet.2013.05.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  37 in total

1.  miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.

Authors:  Leiguang Ye; Hui Wang; Baogang Liu
Journal:  Tumour Biol       Date:  2015-08-16

2.  Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.

Authors:  Piyush Joshi; Tatsuya Seki; Shinobu Kitamura; Andrea Bergano; Bongyong Lee; Ranjan J Perera
Journal:  RNA Biol       Date:  2019-06-16       Impact factor: 4.652

3.  Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

Authors:  Lei Wang; Yan-Feng Shen; Zhi-Min Shi; Xiao-Juan Shang; Dong-Ling Jin; Feng Xi
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

Review 4.  Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.

Authors:  Fanglong Wu; Kelsey J Weigel; Hongmei Zhou; Xiao-Jing Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

5.  LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.

Authors:  Meihua Liang; Jinliang Jia; Lili Chen; Biyue Wei; Qiang Guan; Zhaoming Ding; Jiawei Yu; Rui Pang; Guoqing He
Journal:  Endocrine       Date:  2019-04-27       Impact factor: 3.633

6.  Combination of structural and vascular optical coherence tomography for differentiating oral lesions of mice in different carcinogenesis stages.

Authors:  Ping-Hisen Chen; Chien-Hsien Wu; Yi-Fen Chen; Yi-Chen Yeh; Bo-Han Lin; Kuo-Wei Chang; Pei-Yu Lai; Ming-Chih Hou; Ching-Liang Lu; Wen-Chuan Kuo
Journal:  Biomed Opt Express       Date:  2018-03-02       Impact factor: 3.732

7.  MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.

Authors:  Jun Zhang; Jianguang Lv; Feng Zhang; Hongmin Che; Qiwei Liao; Wobin Huang; Shaopeng Li; Yuqian Li
Journal:  J Neurooncol       Date:  2017-05-27       Impact factor: 4.130

8.  MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.

Authors:  Ahmet Taner Sümbül; Bülent Göğebakan; Süleyman Bayram; Celal Yücel Batmacı; Serdar Öztuzcu
Journal:  Tumour Biol       Date:  2015-07-08

9.  MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2.

Authors:  Jian Liu; Yanqin Huang; Hongqian Wang; Denghai Wu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

10.  MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.

Authors:  Chen-Yu Wang; Long Hua; Juan Sun; Kun-Hou Yao; Jiang-Tao Chen; Jun-Jie Zhang; Jun-Hong Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.